Chemotherapy variations - baridirects

Clinical Trial Associated with Invasive Lobular Carcinoma . Posted on June 18, 2013 View this journey (29 Experiences)

Was elected to arm without Adriamycin; will be receiving only Cytoxan and Taxotere. The study will last 10 years, during which I will be followed regularly by my medical oncologist. The purpose is to discover the most effective combination of existing therapeutic agents with the least side effects. Evidently, the combination I'm being given is more common in Europe than in the U.S.

Read and answer Invasive Lobular Carcinoma questions.